DONY A.
- Country
- France
- Department
- Hematology
Research Overview
- TRANSCRIPT: An open label, controlled, randomized multicentric international study evaluating the benefit of autologous stem cell transplantation after complete response in frontline setting patients with T cell-lymphoma
- Phase III Study of Mosunetuzumab and Lenalidomide Versus Anti-CD20 Monoclonal Antibody and Chemotherapy in Untreated FLIPI 2-5 Follicular Lymphoma
- Minimal Residual Disease-Adapted Strategy in Multiple Myeloma: Evaluation of Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone in Transplant-Eligible Patients
Data & Insights
Has run more than one trial at 97 of 229 partner sites.
Specializations
Multiple Myeloma Research
The investigator specializes in treating multiple myeloma, focusing on both newly diagnosed and relapsed/refractory cases. Their research encompasses innovative therapeutic approaches including autologous stem cell transplantation and minimal residual disease monitoring strategies.
- Novel Treatment Combinations
- Maintenance Therapy Optimization
- Disease Response Assessment
Their work extends to evaluating continuous versus fixed-duration therapies and exploring novel drug combinations for treatment optimization.
T-Cell Lymphoma Studies
The investigator conducts research in peripheral T-cell lymphoma (PTCL) treatment, with particular attention to relapsed/refractory disease management. Their work includes evaluation of novel therapeutic approaches and transplantation strategies.
- Response-Adapted Therapy
- Transplantation Outcomes
- Novel Agent Combinations
Their research encompasses various PTCL subtypes and innovative treatment paradigms.
Follicular Lymphoma Expertise
The investigator focuses on advancing treatment options for follicular lymphoma, including studies of both treatment-naive and relapsed/refractory cases. Their research evaluates novel therapeutic combinations and targeted approaches.
- First-line Treatment Strategies
- Combination Therapy Assessment
- Progressive Disease Management
Their work includes evaluation of immunotherapy combinations and risk-stratified treatment approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.